Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1Phase 1 1

Status

Not yet recruiting 2Recruiting 1

Sponsor Class

OTHER 2NIH 1

Study Type

Interventional 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Brain Neoplasms 31Carcinoma, Non-Small-Cell Lung 27Prostatic Neoplasms 26Lung Neoplasms 20Neoplasm Metastasis 19Melanoma 12Breast Neoplasms 12Pancreatic Neoplasms 8Carcinoma, Renal Cell 8Carcinoma, Hepatocellular 7Small Cell Lung Carcinoma 5Colorectal Neoplasms 5Neoplasms 4Urinary Bladder Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3NSCLC 3Meningioma 3Hematologic Neoplasms 3Gastrointestinal Neoplasms 3Uveal Melanoma 2Unresectable Locally Recurrent Rectal Cancer 2Thyroid Neoplasms 2Sarcoma 2Liver Neoplasms 2Head and Neck Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Merkel Cell 2Adenocarcinoma 2Uterine Cervical Neoplasms 1Urogenital Neoplasms 1

Interventions

Gemcitabine 31pembrolizumab 20Cisplatin 20Magnetic Resonance Spectroscopy 18Specimen Handling 16durvalumab 11Mitomycin 11enfortumab vedotin 9avelumab 9Nivolumab 9Cystoscopy 9Fluorouracil 8Radiation 7Carboplatin 7Radiotherapy 6Immunoglobulin G 6Docetaxel 6Disulfides 6Cystectomy 6Transurethral Resection of Bladder 5Mitozytrex 5Biopsy 5sacituzumab govitecan 4erdafitinib 4dehydroftorafur 4atezolizumab 4Standard of Care 4Platinum 41,2-diaminocyclohexaneplatinum II citrate 4tremelimumab 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Urinary Bladder Neoplasms × Radiosurgery × 90 days × Clear all
NCT04235777 2026-05-20

Bintrafusp Alfa (M7824) and PDS01ADC Alone and in Combination With Stereotactic Body Radiation Therapy (SBRT) in Adults With Metastatic Non-Prostate Genitourinary Malignancies

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
100 enrolled
Genitourinary

Urinary Bladder Neoplasms, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Urogenital Neoplasms

NCT07579195 2026-05-14

Consolidative Therapy After EV + Pembrolizumab in Muscle Invasive Bladder Cancer, REINFORCE Trial

University of Washington

Phase 1/2 Not yet recruiting
12 enrolled
Genitourinary

Urinary Bladder Neoplasms

NCT07414992 2026-05-01

A Study of Radiation Therapy and Cemiplimab With or Without Fianlimab In People With Bladder Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Not yet recruiting
44 enrolled
Genitourinary

Urinary Bladder Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡